ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Ankylosing Spondylitis

Ankylosing Spondylitis

@Lightspring/Shutterstock,com

In this article, we highlight a recent NEJM review that addresses the difference between axial spondyloarthritis and ankylosing spondylitis.

©Mirana/Shutterstock.com

Axial spondyloarthritis (SpA) often goes undiagnosed and is more common than previously thought, a study shows.

@Lightspring/Shutterstock.com

The diagnosis and treatment of spondyloarthritis (axSpA) and ankylosing spondylitis (AS) for primary healthcare providers.

©SutthaBurawonk/Shutterstock.com

EULAR 2016: Secukinumab prevents radiographic progression in 80 percent of ankylosing spondylitis patients and provides sustained improvements.

Biosimilar CT-P13 may offer an effective option to infliximab for ankylosing spondylitis.

©AlilaMedicalMedia/Shutterstock.com

Approval of secukinumab for ankylosing spondylitis and psoriatic arthritis marks a milestone in rheumatic disease.

©bleakstar/Shuttersstock.com

The ACR has new treatment guidelines for ankylosing spondylitis, emphasizing strong evidence for treatment with NSAIDs and TNF blockers.

Pages

Subscribe to Ankylosing Spondylitis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.